Document is current
Any future updates will be listed below
-
Authors
Zarnecki, K. G.
Kristianto, J.
Charlson, J.
Wilson, B.
Blank, R. D.
Shaker, J. L. https://orcid.org/0000-0002-6266-1029
-
Funding
Funding for this research was provided by:
National Institutes of Health (AR54753)
- License Information
-
More Information
Article History
Received: 29 November 2018
Accepted: 21 April 2019
First Online: 11 May 2019
Compliance with ethical standards
:
: None directly related to this work, Jasmin Kristianto Employee: Unity Biotechnology John Charlson Advisory Board:Immune Design Clinical trial funding: Lilly Oncology Robert D. Blank Consultant: Amgen, Novo-Nordisk, Radius Health, Ultragenyx Authorship Royalties: UpToDate, McGraw-Hill Ownership Interest: JangoBio, Abbott Laboratories, Abbvie Joseph L. Shaker Consultant Shire, Alexion, Ultragenyx Authorship Royalties: McGraw-Hill.
